Upregulation of PD-1 and PD-L1 has been described in interstitial lung diseases where blockade of the PD-1 pathway has proven to be capable of restoring T-cell function and proliferative capacity in granulomatous diseases, such as chronic beryllium disease and sarcoidosis [60]. Here, PDCD1 is linked to interstitial lung disease.